Wettig Thane bought FGEN
March 24, 2025 · Form 4 insider transaction
Wettig Thane bought 145,000 shares of FibroGen Incorporated at $0.35 per share, a transaction worth $50.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
145,000
Price
$0.35
Total value
$50.7K
InsiderWettig Thane
RoleOfficer, Director
CompanyFibroGen Incorporated (FGEN)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 24, 2025
Filing dateMarch 25, 2025
Shares owned after543,329
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.34 to $0.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.